Amphastar Pharmaceuticals, Inc. (AMPH) stock
AMPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3033% below fair value
$28.87+0.27 (+0.94%)
Close on Nov 12, 2026Market cap $1.23BP/E 13.1Yield –
Amphastar Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Amphastar Pharmaceuticals's profit margin for the twelve months ending Sep 30, 2026 was 13.3%. For fiscal 2025 it was 13.6%, against 21.8% the year before. The highest annual figure on record is 21.8% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 13.6% | −8.2 |
| FY2024 | Dec 31, 2024 | 21.8% | +0.4 |
| FY2023 | Dec 31, 2023 | 21.3% | +3.0 |
| FY2022 | Dec 31, 2022 | 18.3% | +4.1 |
| FY2021 | Dec 31, 2021 | 14.2% | +13.8 |
| FY2020 | Dec 31, 2020 | 0.4% | −14.8 |
| FY2019 | Dec 31, 2019 | 15.2% | +17.1 |
| FY2018 | Dec 31, 2018 | -1.9% | −3.5 |
| FY2017 | Dec 31, 2017 | 1.5% | −2.3 |
| FY2016 | Dec 31, 2016 | 3.8% | +5.0 |
| FY2015 | Dec 31, 2015 | -1.1% | +4.0 |
| FY2014 | Dec 31, 2014 | -5.1% | −10.2 |
| FY2013 | Dec 31, 2013 | 5.2% | −3.7 |
| FY2012 | Dec 31, 2012 | 8.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 18.2% | +9.1 |
| Q2 FY2026 | Jun 30, 2026 | 16.5% | −1.3 |
| Q1 FY2026 | Mar 31, 2026 | 3.8% | −11.1 |
| Q4 FY2025 | Dec 31, 2025 | 13.3% | −7.0 |
| Q3 FY2025 | Sep 30, 2025 | 9.0% | −12.1 |
| Q2 FY2025 | Jun 30, 2025 | 17.8% | −3.0 |
| Q1 FY2025 | Mar 31, 2025 | 14.8% | −10.3 |
| Q4 FY2024 | Dec 31, 2024 | 20.4% | +0.0 |
| Q3 FY2024 | Sep 30, 2024 | 21.1% | −6.1 |
| Q2 FY2024 | Jun 30, 2024 | 20.8% | +2.9 |
| Q1 FY2024 | Mar 31, 2024 | 25.1% | +6.5 |
| Q4 FY2023 | Dec 31, 2023 | 20.3% | −4.8 |
| Q3 FY2023 | Sep 30, 2023 | 27.3% | +14.0 |
| Q2 FY2023 | Jun 30, 2023 | 17.9% | +3.9 |
| Q1 FY2023 | Mar 31, 2023 | 18.6% | −1.6 |
| Q4 FY2022 | Dec 31, 2022 | 25.1% | +8.8 |
| Q3 FY2022 | Sep 30, 2022 | 13.2% | −13.1 |
| Q2 FY2022 | Jun 30, 2022 | 14.0% | +6.4 |
| Q1 FY2022 | Mar 31, 2022 | 20.1% | +15.3 |
| Q4 FY2021 | Dec 31, 2021 | 16.3% | +22.9 |
| Q3 FY2021 | Sep 30, 2021 | 26.3% | +21.6 |
| Q2 FY2021 | Jun 30, 2021 | 7.6% | +7.9 |
| Q1 FY2021 | Mar 31, 2021 | 4.9% | +0.2 |
| Q4 FY2020 | Dec 31, 2020 | -6.5% | −5.3 |
| Q3 FY2020 | Sep 30, 2020 | 4.7% | +3.1 |
| Q2 FY2020 | Jun 30, 2020 | -0.2% | −60.7 |
| Q1 FY2020 | Mar 31, 2020 | 4.7% | +3.6 |
| Q4 FY2019 | Dec 31, 2019 | -1.2% | −3.3 |
| Q3 FY2019 | Sep 30, 2019 | 1.6% | −1.5 |
| Q2 FY2019 | Jun 30, 2019 | 60.5% | +64.5 |
| Q1 FY2019 | Mar 31, 2019 | 1.1% | +13.3 |
| Q4 FY2018 | Dec 31, 2018 | 2.1% | −0.3 |
| Q3 FY2018 | Sep 30, 2018 | 3.2% | +3.0 |
| Q2 FY2018 | Jun 30, 2018 | -4.0% | −7.0 |
| Q1 FY2018 | Mar 31, 2018 | -12.2% | −13.8 |
| Q4 FY2017 | Dec 31, 2017 | 2.4% | +6.7 |
| Q3 FY2017 | Sep 30, 2017 | 0.2% | – |
| Q2 FY2017 | Jun 30, 2017 | 3.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 1.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -4.3% | – |
See a number that looks wrong?